Biofrontera Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio0.230.120.855.34
P/B Ratio1.910.881.0211.35
Price/Tangible Book1.921.941.1716.31
Enterprise Value Ratios
EV/Revenue0.180.015.27
Profitability & Returns
Return on Equity (ROE)-3.85%-1.40%-0.04%-4.39%
Return on Assets (ROA)-0.43%-0.34%-0.26%-0.24%-0.20%
Return on Capital Employed (ROCE)-1.71%-2.17%-0.72%-0.37%-0.42%
Leverage & Solvency Ratios
Debt/Equity1.111.130.06
Liquidity Ratios
Current Ratio1.721.282.063.354.43
Quick Ratio0.930.361.512.912.57
Efficiency Ratios
Asset Turnover1.490.860.550.620.71
Inventory Turnover2.121.932.612.211.03
Yield & Distribution Ratios
Earnings Yield-2.10%-4.79%-0.03%-0.29%
FCF Yield-1.22%-5.92%-0.66%-0.21%
Buyback Yield-2.57%-0.46%-1.40%